United Vaccines, Inc. v. Diamond Animal Health, Inc.

409 F. Supp. 2d 1083, 2006 U.S. Dist. LEXIS 1208, 2006 WL 120165
CourtDistrict Court, W.D. Wisconsin
DecidedJanuary 12, 2006
Docket05-C-604-C
StatusPublished
Cited by4 cases

This text of 409 F. Supp. 2d 1083 (United Vaccines, Inc. v. Diamond Animal Health, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United Vaccines, Inc. v. Diamond Animal Health, Inc., 409 F. Supp. 2d 1083, 2006 U.S. Dist. LEXIS 1208, 2006 WL 120165 (W.D. Wis. 2006).

Opinion

*1087 OPINION and ORDER

CRABB, District Judge.

In this civil action for injunctive and monetary relief, plaintiff United Vaccines, Inc. asserts a variety of contract and tort claims arising out of an agreement it signed with defendant Diamond Animal Health, Inc., a wholly owned subsidiary of defendant Heska Corporation, concerning the manufacture and delivery of animal vaccines. The case was removed to this court from the Circuit Court for Dane County on October 13, 2005. Jurisdiction is predicated on diversity of citizenship. 28 U.S.C. § 1332(a)(1). (In the notice of removal, defendants state that plaintiff is a corporation formed under the laws of Indiana with its principal place of business in Madison, Wisconsin; defendant Diamond Animal Health is a corporation formed under the laws of Iowa with its principal place of business in Des Moines, Iowa; and defendant Heska Corporation is a corporation formed under the laws of Delaware with its principal place of business in Loveland, Colorado. The amount in controversy is alleged to be in excess of $75,000.00.)

The parties tripped over themselves and each other in the early stages of this case, with the result a crowded and confusing docket. On October 20, 2005, defendants filed their answer to plaintiffs complaint and a motion to dismiss pursuant to Fed. R.Civ.P. 9(b) and 12(b)(6). On November 16, 2005, plaintiff filed a brief in opposition to the motion to dismiss and an amended complaint that purported to address some of the deficiencies that defendants highlighted in their motion to dismiss. On November 30, 2005, defendants filed a reply brief in support of their motion to dismiss the original complaint and a motion to dismiss the amended complaint. At present, there are two fully briefed motions to dismiss pending in this case.

“When a plaintiff files an amended complaint, the new complaint supersedes all previous complaints and controls the case from that point forward.” Massey v. Helman, 196 F.3d 727, 735 (7th Cir.1999). Therefore, the original complaint is no longer the operative pleading in this case and defendants’ motion to dismiss the original complaint will be denied as moot. However, because the two complaints are identical in almost all respects, I will consider the arguments presented in support of and in opposition to defendants’ motion to dismiss the original complaint to the extent they are applicable to the amended complaint.

For the reasons stated below, defendants’ motion to dismiss the amended complaint will be granted in part and denied in part. I will dismiss plaintiffs negligent misrepresentation and strict responsibility for negligent misrepresentation claims because they are barred by the economic loss doctrine. However, the doctrine does not bar a contract action based on an intentional misrepresentation. Therefore, plaintiff will be allowed to proceed on this claim. Defendants’ motion will be denied with respect to their argument that plaintiff failed to plead its fraud claim with sufficient particularity. In addition, defendants’ motion to dismiss will be denied with respect to plaintiffs breach of contract and breach of warranty claims against defendant Heska because plaintiff has alleged that defendant Heska controlled defendant Diamond in the negotiating process. Finally, defendants’ motion will be granted with respect to their argument that the contract precludes plaintiff from obtaining damages for lost sales and lost customers. If plaintiff prevails on its intentional misrepresentation claim and elects to affirm the contract and seek damages, it will not be allowed to recover damages for lost sales and lost customers.

*1088 I draw the following factual allegations from the amended complaint, the notice of removal and the contract, which is referred to in the amended complaint as the “Manufacturing Agreement” and which was submitted in connection with defendants’ motion to dismiss the original complaint. Levenstein v. Salafsky, 164 F.3d 345, 347 (7th Cir.1998) (consideration of contract attached to motion to dismiss appropriate if contract is referred to in complaint and is central to plaintiffs claims).

ALLEGATIONS OF FACT

Plaintiff United Vaccines, Inc. is a corporation formed under the laws of Indiana with its principal place of business in Madison, Wisconsin. Plaintiff is a wholly owned subsidiary of Harlan Sprague Dawley, Inc. and is in the business of providing animal vaccines and related products to purchasers around the world. Defendant Diamond Animal Health, Inc. (Diamond) is a corporation formed under the laws of Iowa with its principal place of business in Des Moines, Iowa. Defendant Diamond Animal Health is a wholly owned subsidiary of defendant Heska Corporation (Heska), which is a Delaware corporation with its principal place of business in Loveland, Colorado. Defendants manufacture products for companies in the biotechnology industry, including plaintiff.

Plaintiff provides many of its products throughout the United States, Canada and Europe to mink ranchers, who seasonally vaccinate mink against a variety of common illnesses, including distemper. In order for plaintiffs products to provide protection against distemper, they must be used at a particular time of the year. If plaintiffs customers do not vaccinate mink at the proper time of the year, the vaccinations may not protect the animals against distemper.

In 2001, plaintiff and defendants began negotiating terms of an agreement whereby defendant Diamond would manufacture certain vaccines for plaintiff. During those negotiations, defendants were made aware of the needs of plaintiffs customers and the intended uses for the vaccines. Defendants’ representatives told plaintiffs representatives that defendant Diamond had the requisite experience, knowledge, expertise, facilities and personnel to manufacture the products listed in the agreement and to perform its other obligations in safe, lawful and workmanlike manner. This representation was first made in June and July 2001 by Mike McGinley, Vice President of Operations and Technical Affairs for defendant Heska, and Mike Johnson and Laurie Peterson, technical and compliance employees for defendant Diamond to Connie Phillips, Ed Carroll and Robert Norberg, employees of plaintiff. Additionally, McGinley, Johnson and Peterson told plaintiff that defendant Diamond was willing to produce plaintiffs products in quantities and potency sufficient to satisfy the needs of plaintiffs customers and to deliver the products in a timely manner so that plaintiffs customers could vaccinate their animals at the appropriate time of year.

Plaintiff relied on these representations in entering into the Manufacturing Agreement. Without them, plaintiff would not have entered into the agreement. The representations were incorporated into the agreement, which the parties signed on January 1, 2003. Defendant made these representations negligently or fraudulently.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
W.D. Wisconsin, 2026
Vidafuel, Inc. v. Kerry, Inc.
Court of Appeals of Tennessee, 2024
KTM Health Care Inc. v. SG Nursing Home LLC
2018 UT App 152 (Court of Appeals of Utah, 2018)
Larchmont Holdings, LLC v. N. Shore Servs., LLC
292 F. Supp. 3d 833 (W.D. Wisconsin, 2017)
CMFG Life Insurance v. UBS Securities
30 F. Supp. 3d 822 (W.D. Wisconsin, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
409 F. Supp. 2d 1083, 2006 U.S. Dist. LEXIS 1208, 2006 WL 120165, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-vaccines-inc-v-diamond-animal-health-inc-wiwd-2006.